Matrix metalloproteinase-9 inhibition prevents aquaporin-4 depolarization-mediated glymphatic dysfunction in Parkinson's disease

被引:30
|
作者
Si, Xiaoli [1 ,2 ]
Dai, Shaobing [3 ]
Fang, Yi [1 ]
Tang, Jiahui [1 ]
Wang, Zhiyun [1 ]
Li, Yaolin [1 ]
Song, Zhe [1 ]
Chen, Ying [1 ]
Liu, Yi [1 ]
Zhao, Guohua [1 ,2 ,4 ]
Zhang, Baorong [1 ]
Pu, Jiali [1 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Neurol, Hangzhou 310009, Zhejiang, Peoples R China
[2] Zhejiang Univ, Affiliated Hosp 4, Int Inst Med, Sch Med,Dept Neurol, Yiwu 322000, Zhejiang, Peoples R China
[3] Zhejiang Univ, Womens Hosp, Sch Med, Dept Anesthesiol, Hangzhou 310009, Zhejiang, Peoples R China
[4] Zhejiang Univ, Sch Med, Affiliated Hosp 4, Dept Neurol, N1 Ave, Yiwu 322000, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
Parkinson's disease; Glymphatic system; Aquaporin-4; Matrix metalloproteinase-9; Metabolomics; BETA-DYSTROGLYCAN; SUBSTANTIA-NIGRA; ALPHA; MODEL;
D O I
10.1016/j.jare.2023.03.004
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Introduction: The glymphatic system offers a perivascular pathway for the clearance of pathological proteins and metabolites to optimize neurological functions. Glymphatic dysfunction plays a pathogenic role in Parkinson's disease (PD); however, the molecular mechanism of glymphatic dysfunction in PD remains elusive. Objective: To explore whether matrix metalloproteinase-9 (MMP-9)-mediated 13-dystroglycan (13 -DG) cleavage is involved in the regulation of aquaporin-4 (AQP4) polarity-mediated glymphatic system in PD. Methods: 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD and A53T mice were used in this study. The glymphatic function was evaluated using ex vivo imaging. TGN-020, an AQP4 antagonist, was administered to investigate the role of AQP4 in glymphatic dysfunction in PD. GM6001, an MMP-9 antagonist, was administered to investigate the role of the MMP-9/13-DG pathway in regulating AQP4. The expression and distribution of AQP4, MMP-9, and 13 -DG were assessed using western blotting, immunofluorescence, and co-immunoprecipitation. The ultrastructure of basement membrane (BM)astrocyte endfeet was detected using transmission electron microscopy. Rotarod and open-field tests were performed to evaluate motor behavior. Results: Perivascular influx and efflux of cerebral spinal fluid tracers were reduced in MPTP-induced PD mice with impaired AQP4 polarization. AQP4 inhibition aggravated reactive astrogliosis, glymphatic drainage restriction, and dopaminergic neuronal loss in MPTP-induced PD mice. MMP-9 and cleaved 0 -DG were upregulated in both MPTP-induced PD and A53T mice, with reduced polarized localization of 0DG and AQP4 to astrocyte endfeet. MMP-9 inhibition restored BM-astrocyte endfeet-AQP4 integrity and attenuated MPTP-induced metabolic perturbations and dopaminergic neuronal loss. Conclusion: AQP4 depolarization contributes to glymphatic dysfunction and aggravates PD pathologies, and MMP-9-mediated 0 -DG cleavage regulates glymphatic function through AQP4 polarization in PD, which may provide novel insights into the pathogenesis of PD. (c) 2024 The Authors. Published by Elsevier B.V. on behalf of Cairo University. This is an open access article under the CC BY -NC -ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:125 / 136
页数:12
相关论文
共 50 条
  • [21] Secretion of Matrix Metalloproteinase-9 from Astrocytes by Inhibition of Tonic P2Y14-Receptor-Mediated Signal(s)
    Manao Kinoshita
    Kaoru Nasu-Tada
    Kayoko Fujishita
    Kaoru Sato
    Schuichi Koizumi
    Cellular and Molecular Neurobiology, 2013, 33 : 47 - 58
  • [22] Secretion of Matrix Metalloproteinase-9 from Astrocytes by Inhibition of Tonic P2Y14-Receptor-Mediated Signal(s)
    Kinoshita, Manao
    Nasu-Tada, Kaoru
    Fujishita, Kayoko
    Sato, Kaoru
    Koizumi, Schuichi
    CELLULAR AND MOLECULAR NEUROBIOLOGY, 2013, 33 (01) : 47 - 58
  • [23] A "glympse" into neurodegeneration: Diffusion MRI and cerebrospinal fluid aquaporin-4 for the assessment of glymphatic system in Alzheimer's disease and other dementias
    Sacchi, Luca
    D'Agata, Federico
    Campisi, Corrado
    Arcaro, Marina
    Carandini, Tiziana
    Orzsik, Balazs
    Dal Maschio, Vera Pacoova
    Fenoglio, Chiara
    Pietroboni, Anna Margherita
    Ghezzi, Laura
    Serpente, Maria
    Pintus, Manuela
    Conte, Giorgio
    Triulzi, Fabio
    Lopiano, Leonardo
    Galimberti, Daniela
    Cercignani, Mara
    Bozzali, Marco
    Arighi, Andrea
    HUMAN BRAIN MAPPING, 2024, 45 (12)
  • [24] Potential Contribution of Hypoxia-Inducible Factor-1α, Aquaporin-4, and Matrix Metalloproteinase-9 to Blood–Brain Barrier Disruption and Brain Edema After Experimental Subarachnoid Hemorrhage
    Zhong Wang
    Cheng-Jie Meng
    Xu-Ming Shen
    Zhang Shu
    Chao Ma
    Guo-Qing Zhu
    Hui-Xiang Liu
    Wei-Chun He
    Xue-Bo Sun
    Lei Huo
    Jian Zhang
    Gang Chen
    Journal of Molecular Neuroscience, 2012, 48 : 273 - 280
  • [25] Ginkgolide B can alleviate spinal cord glymphatic system dysfunction and provide neuroprotection in painful diabetic neuropathy rats by inhibiting matrix metalloproteinase-9
    Li, Jiang
    Jia, Shuaiying
    Song, Yuehan
    Xu, Wenmei
    Lin, Jingyan
    NEUROPHARMACOLOGY, 2024, 250
  • [26] Matrix Metalloproteinase-9 rs17576 Gene Polymorphism and Behcet's Disease: Is There an Association?
    Kamal, Asmaa
    Elgengehy, Fatema T.
    Abd Elaziz, Mohamed Momtaz
    Gamal, Sherif M.
    Sobhy, Nesreen
    Medhat, Amira
    El Dakrony, Al Hussein M.
    IMMUNOLOGICAL INVESTIGATIONS, 2017, 46 (05) : 460 - 468
  • [27] Early matrix metalloproteinase-9 inhibition post-myocardial infarction worsens cardiac dysfunction by delaying inflammation resolution
    Iyer, Rugmani Padmanabhan
    Bras, Lisandra E. de Castro
    Patterson, Nicolle L.
    Bhowmick, Manishabrata
    Flynn, Elizabeth R.
    Asher, Majdouline
    Cannon, Presley L.
    Deleon-Pennell, Kristine Y.
    Fields, Gregg B.
    Lindsey, Merry L.
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2016, 100 : 109 - 117
  • [28] Matrix metalloproteinase-9, its tissue inhibitor (TIMP)-1 and CRP in Alzheimer's disease
    Inspector, M
    Aharon-Perez, J
    Glass-Marmor, L
    Miller, A
    EUROPEAN NEUROLOGY, 2005, 53 (03) : 155 - 157
  • [29] Aquaporin-4 deficiency diminishes the differential degeneration of midbrain dopaminergic neurons in experimental Parkinson's disease
    Zhang, Ji
    Yang, Beibei
    Sun, Hongbin
    Zhou, Yan
    Liu, Mengdi
    Ding, Jianhua
    Fang, Feng
    Fan, Yi
    Hu, Gang
    NEUROSCIENCE LETTERS, 2016, 614 : 7 - 15
  • [30] AQUAPORIN-4 MEDIATES COMMUNICATION BETWEEN ASTROCYTE AND MICROGLIA: IMPLICATIONS OF NEUROINFLAMMATION IN EXPERIMENTAL PARKINSON'S DISEASE
    Sun, H.
    Liang, R.
    Yang, B.
    Zhou, Y.
    Liu, M.
    Fang, F.
    Ding, J.
    Fan, Y.
    Hu, G.
    NEUROSCIENCE, 2016, 317 : 65 - 75